CNBX Pharmaceuticals Inc. Annual Return On Equity in % from 2013 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2024.
  • CNBX Pharmaceuticals Inc. Return On Equity for the quarter ending August 31, 2024 was 29.6 %, a 84.2% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2024 was 29.6 %, a 84.2% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2023 was 188 %.
  • CNBX Pharmaceuticals Inc. annual Return On Equity for 2022 was -2.46K %, a 1669% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 29.6 -158 -84.2% Sep 1, 2023 Aug 31, 2024
2023 188 +2.65K Sep 1, 2022 Aug 31, 2023
2022 -2.46K -2.32K -1669% Sep 1, 2021 Aug 31, 2022
2021 -139 +82.8 +37.3% Sep 1, 2020 Aug 31, 2021
2020 -222 -229 -3094% Sep 1, 2019 Aug 31, 2020
2019 7.42 +145 Sep 1, 2018 Aug 31, 2019
2018 -138 -1.78K -108% Sep 1, 2017 Aug 31, 2018
2017 1.64K +1.57K +2019% Sep 1, 2016 Aug 31, 2017
2016 77.6 -1.73K -95.7% Sep 1, 2015 Aug 31, 2016
2015 1.81K -1.53K -45.9% Sep 1, 2014 Aug 31, 2015
2014 3.34K +3.26K +4510% Sep 1, 2013 Aug 31, 2014
2013 72.4 Sep 1, 2012 Aug 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.